Y-mAbs Therapeutics Inc. (YMAB)
NASDAQ: YMAB
· Real-Time Price · USD
5.26
0.16 (3.14%)
At close: Jun 06, 2025, 3:51 PM
Y-mAbs Therapeutics Revenue
Y-mAbs Therapeutics reported an annual revenue of $87.69M, reflecting a 3.38% growth. For the quarter ending March 31, 2025, Y-mAbs Therapeutics generated $20.9M in revenue.
Revenue (ttm)
$87.69M
Revenue Growth
3.38%
Price / Sales Ratio
3.96
Revenue / Employee
$843.13K
Employees
104
Market Cap
238.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|